These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3544824)

  • 21. Serum oxidized LDL is inversely associated with HDL2-cholesterol subclass in renal failure patients on hemodialysis.
    Samouilidou E; Karpouza A; Grapsa E; Tzanatou-Exarchou H
    Nephron Clin Pract; 2010; 115(4):c289-94. PubMed ID: 20424480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma.
    Patsch W; Brown SA; Morrisett JD; Gotto AM; Patsch JR
    Clin Chem; 1989 Feb; 35(2):265-70. PubMed ID: 2914371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.
    Mekki K; Bouchenak M; Remaoun M; Belleville JL
    Med Sci Monit; 2004 Aug; 10(8):CR439-46. PubMed ID: 15277993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.
    Piperi C; Kalofoutis C; Tzivras M; Troupis T; Skenderis A; Kalofoutis A
    Mol Cell Biochem; 2004 Oct; 265(1-2):57-61. PubMed ID: 15543934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects.
    Sunami Y; Motoyama M; Kinoshita F; Mizooka Y; Sueta K; Matsunaga A; Sasaki J; Tanaka H; Shindo M
    Metabolism; 1999 Aug; 48(8):984-8. PubMed ID: 10459562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cholesterol content of HDL2 and HDL3 subfractions of high density lipoproteins in different normocholesterolemic populations.
    Neel D; Beaudry P; Erlich D; Turpin E; Goussault Y; Dreux C
    Clin Chim Acta; 1984 Oct; 142(3):319-24. PubMed ID: 6488565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
    Gluba-Brzózka A; Franczyk B; Banach M; Rysz-Górzyńska M
    Int Urol Nephrol; 2017 Jan; 49(1):155-164. PubMed ID: 27942970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients.
    Rubiés-Prat J; Romero R; Chacón P; Masdeu S; Griño J; Caralps A
    Nephron; 1983; 35(3):171-4. PubMed ID: 6355878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperlipidaemia in uraemic patients under chronic haemodialysis. Correlation with serum lipoprotein lipase and insulin levels.
    Sobh MA; Shamaa SA; el-Gayar AM; el-Sharabacy MM
    Int Urol Nephrol; 1989; 21(6):667-74. PubMed ID: 2700187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition.
    Hong ML; James RW; Grab B; Pometta D
    Atherosclerosis; 1988 Feb; 69(2-3):241-8. PubMed ID: 3126751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective determination of cholesterol in high density lipoprotein subfractions (HDL2 and HDL3) in patients with cerebral and peripheral arteriosclerosis.
    Fellin R; Baroni L; Baiocchi MR; Baldo Enzi G; Grego F; Valerio G
    Clin Chim Acta; 1985 Apr; 147(3):233-40. PubMed ID: 3995773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
    Bulum T; Duvnjak L; Prkacin I
    Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients.
    Argani H; Rahbaninoubar M; Ghorbanihagjo A; Golmohammadi Z; Rashtchizadeh N
    Nephron Clin Pract; 2005; 101(4):c174-9. PubMed ID: 16103722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.